Sun Jian David Sells Shares of 111, Inc.

Insider Sun Jian David sold 12,000 shares of 111, Inc. on June 9, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 2:01 PM EDT

Key Points

Sun Jian David sold 12,000 shares of 111, Inc. valued at $2,760 on June 9, 2026, at an average price of $0.23 per share.
111, Inc. trades on NasdaqGM with a market cap of $40.2 million and a forward P/E of 32.64.
Renaissance Technologies LLC and Serenus Wealth Advisors, LLC adjusted their positions in 111, Inc. recently.

Sun Jian David, an insider at 111, Inc. (NasdaqGM: YI), sold 12,000 shares of the company on June 9, 2026. The shares were sold at an average price of $0.23 each, amounting to a total value of $2,760. This transaction was not part of a prearranged trading plan.

Insider Buying and Selling at 111, Inc.

On June 9, 2026, Sun Jian David sold 12,000 shares at $0.23 per share. Following this, on June 10, he sold an additional 115,440 shares at $0.22 each. Further sales included 111,100 shares on June 11, 2026, and 58,800 shares on June 15, 2026, all at $0.23 per share. Another insider, Chen Yang Luke, sold 49,920 shares at $0.23 on June 12, and 44,000 shares at the same price on June 15, 2026.

Other Institutional Activity in 111, Inc.

Renaissance Technologies LLC increased its holdings in 111, Inc. by 300 shares, bringing its total to 13,014 shares worth approximately $84,851. Serenus Wealth Advisors, LLC, however, reduced its position by 64 shares, leaving it with 4,320 shares valued at about $321,334. Citigroup Inc. added 207 shares to its holdings, now owning 207 shares valued at $1,341. Meanwhile, UBS Group AG cut its position significantly, selling 203 shares to hold 100 shares worth $652.

111, Inc. Stock Snapshot

Shares of 111, Inc. (NasdaqGM: YI) recently traded around $4.57. The company has a market capitalization of approximately $40.2 million and a forward P/E ratio of 32.64. Its beta is 0.609, indicating lower volatility compared to the market. The stock's 52-week range is between $2.48 and $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40. The company has a current ratio of 1.084 and a quick ratio of 0.366, with a debt-to-equity ratio of 150.925.

Recent Earnings

111, Inc. reported revenue of approximately $11.39 billion, experiencing a revenue decline of 33.1%. The company posted a net margin of -0.75% and a return on equity of -14.84%. The next earnings release is scheduled for March 19, 2026.

About 111, Inc.

111, Inc. operates an integrated online and offline platform in the healthcare market in China. It offers supply chain integration services, product promotion, customer analytics, and more. The company runs an online wholesale pharmacy and a retail pharmacy that provides a wide range of health and wellness products. Founded in 2010 and headquartered in Shanghai, 111, Inc. serves pharmacies, pharmaceutical companies, and medical professionals, providing services that include online consultation and e-prescription.

Bottom Line

Sun Jian David's recent sale of shares highlights insider trading activity at 111, Inc. Investors track such transactions for potential insights, although they don't necessarily indicate the company’s future performance. As a reminder, insider trades are reported after they occur, and 13F filings are historical snapshots that may not reflect current positions.